1 completed, 1 not yet recruiting, 1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Buerger Disease: new trials by email Literature Review of Buerger Disease trials Research Report on Buerger Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease BOTOX INJECTION - Buerger Disease, Raynaud Syndrome | Phase 3 | Not yet recruiting | University Hospital, Toulouse | 8 | 2027-01-01 | 2026-07-23 |
| Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI) CLBS12, SOC - Critical Limb Ischemia, Buerger Disease | Phase 2 | Completed | Lisata Therapeutics, Inc. | 33 | 2017-11-01 | 2024-10-09 |
| TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation Autologous Bone Marrow Mononuclear Cell Implantation - Buerger Disease, Arteriosclerosis Obliterans | Unknown | Nagoya University | 2003-08-01 | 2005-12-30 |
Thromboangiitis Obliterans (3) · Chronic Limb-Threatening Ischemia (2) · Arteriosclerosis Obliterans (1) · Raynaud Disease (1)
Arterial Occlusive Diseases (3) · Cardiovascular Diseases (3) · Peripheral Vascular Diseases (3) · Vascular Diseases (3) · Vasculitis (3) · Arteriosclerosis (2) · Atherosclerosis (2) · Chronic Disease (2) · Disease Attributes (2) · Ischemia (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Peripheral Arterial Disease (2) · Embolism and Thrombosis (1) · Livedoid Vasculopathy (1)
Botulinum Toxins (1) · Standard of Care (1) · betibeglogene autotemcel (1)
Lisata Therapeutics, Inc. (1) · Nagoya University (1) · University Hospital, Toulouse (1)
Japan (2) · France (1)
Julie Malloizel-Delaunay, MD (1) · Kristen K Buck, MD (1) · Toyoaki Murohara, MD, PhD (1)